Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01973322
What this trial is testing

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study

Who this might be right for
Malignant Melanoma of Skin Stage IIIMalignant Melanoma of Skin Stage IV
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 34
Testing effectiveness (Phase 2)Temporarily pausedNCT05756556
What this trial is testing

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

Who this might be right for
MelanomaMalignant Melanoma
ImmVira Pharma Co. Ltd 68
Large-scale testing (Phase 3)Study completedNCT01989572
What this trial is testing

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more
National Cancer Institute (NCI) 815
Early research (Phase 1)Study completedNCT00091143
What this trial is testing

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04200040
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients

Who this might be right for
Melanoma (Skin)
OrienGene Biotechnology Ltd. 165
Early research (Phase 1)Study completedNCT01066390
What this trial is testing

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bart Neyns 18
Testing effectiveness (Phase 2)Study completedNCT00350597
What this trial is testing

GM-CSF as Adjuvant Therapy of Melanoma

Who this might be right for
Malignant Melanoma
Northern California Melanoma Center 50
Testing effectiveness (Phase 2)Study completedNCT00019890
What this trial is testing

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00636168
What this trial is testing

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Who this might be right for
High Risk Stage III Melanoma
Bristol-Myers Squibb 1,211
Early research (Phase 1)Study completedNCT03159117
What this trial is testing

Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing

High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9
Testing effectiveness (Phase 2)Study completedNCT01740557
What this trial is testing

Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 10
Not applicableLooking for participantsNCT04513028
What this trial is testing

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Kelly McMasters 30
Early research (Phase 1)Ended earlyNCT03865212
What this trial is testing

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00002892
What this trial is testing

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

Who this might be right for
Melanoma (Skin)
Institute of Cancer Research, United Kingdom 1,000
Not applicableStudy completedNCT02794636
What this trial is testing

Interferon Toxicities in Melanoma Treatment

Who this might be right for
Stage III Melanoma
Bristol-Myers Squibb 436
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00107159
What this trial is testing

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 37
Not applicableStudy completedNCT00828126
What this trial is testing

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 38
Next Page